Log In
Print
BCIQ
Print
Print this Print this
 

MVA85A-IMX313

  Manage Alerts
Collapse Summary General Information
Company Imaxio S.A.
DescriptionViral vector vaccine encoding antigen 85A fused to Imaxio's IMX313 antigen re-engineering technology
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationTuberculosis
Indication DetailsPrevent tuberculosis (TB) infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today